AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00434343 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial physical therapy (MPT)
Description: Connective tissue manipulation to all body wall tissues of the abdominal wall, back, buttocks and thighs that clinically were found to contain connective tissue abnormalities and/or myofascial trigger point release to painful myofascial trigger points
Study NCT02102360 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Anorganic Bovine Bone
Description: used to improve periodontal regenerative procedures.
Study NCT02102360 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Enamel Matrix Derivative
Description: used to improve periodontal regenerative procedures.
Study NCT02992561 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: FORNET (adapted version)
Study NCT04309071 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Salivary insulin responses to a standardized mixed meal
Study NCT03914300 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study NCT03914300 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT03914300 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT03829670 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cytochrome P450 test
Description: Blood samples will be drawn for cytochrome P450 testing.
Study NCT01511393 — intervention group
Intervention type: OTHER
Intervention: No treatment given
Description: None. Non-interventional study.
Study NCT03333733 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HENRY
Description: HENRY is an 8-week programme delivered in Children's Centres, aiming to provide parents with skills and knowledge to support healthy lifestyles in preschool children and their families. It is currently delivered in \~ 35 local areas across England and Wales by trained health and community practitioners. Training includes:~Centre Level Training: to equip staff with knowledge and skills to promote and provide healthy nutrition within early years settings and support parents to provide healthy family lifestyles and nutrition for their families. The theoretical underpinning combines proven models of behaviour change including the Family Partnership Model, motivational interviewing and solution-focused support.~Practitioner Level Training: to deliver the 8-week HENRY programme, which aims to build parents' skills, knowledge and confidence to change old habits and provide healthier nutrition for their young children.
Study NCT02641899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Oral digoxin 0.5 mg on Day 2 and Day 28
Study NCT04481100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: itraconazole
Description: Oral administration of itraconazole twice daily concurrent with chemoradiation
Study NCT03049631 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Raspberry and fructooligosaccharide
Description: Red raspberries (1 cup equivalent) with fructooligosaccharide (8 g)
Study NCT03049631 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Raspberry
Description: Red raspberries (1 cup equivalent)
Study NCT03668015 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Xylitol then Sorbitol gum
Description: Xylitol gum contains 70% xylitol in addition to gum base, natural flavors, soy lecithin, gum arabic, titanium dioxide, carnuba wax. Sorbitol gum was similar except that xylitol was replaced by 63% sorbitol and 2% maltitol and aspartame was included.
Study NCT03668015 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sorbitol then Xylitol gum
Description: Sorbitol gum was similar except that xylitol was replaced by 63% sorbitol and 2% maltitol and aspartame was included. Xylitol gum contains 70% xylitol in addition to gum base, natural flavors, soy lecithin, gum arabic, titanium dioxide, carnuba wax.
Study NCT00835588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pantoprazole Sodium 40 mg delayed-release tablets
Description: 1 x 40 mg
Study NCT00835588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PROTONIX® 40 mg delayed-release tablets.
Description: 1 x 40 mg
Study NCT00829712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmethylphenidate Hydrochloride
Description: 10 mg Tablet
Study NCT00829712 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmethylphenidate Hydrochloride
Description: 10 mg Tablet
Study NCT03368443 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: treadmill training and overground gait training
Description: The participants will be randomized into two different groups, and they will receive treadmill and overground gait training in one or two rooms.
Study NCT03368443 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: treadmill training and overground gait training
Description: The participants will be randomized into two different groups, and they will receive treadmill and overground gait training in one or two rooms.
Study NCT04311164 — intervention group
Intervention type: OTHER
Intervention: Questionnaire-based survey
Description: The online questionnaire-based survey is composed of multiple items including pre-coded (multiple choice) questions, dichotomous (yes/no) questions, rating scales and validated questionnaire scales to measure general and diabetes/insulin pump-specific behavior, psychological concepts and preferences.
Study NCT04311164 — intervention group
Intervention type: OTHER
Intervention: No intervention given.
Description: No intervention was given.
Study NCT01126463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 188Re-SSS Lipiodol
Description: Hepatic Intra-Arterial Administration of radio-active lipiodol.
Study NCT04159285 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EffEKTiv 2.0 group CBT as continuation treatment after ECT in depressed patients
Description: Group CBT with a maximum number of 8 participants. Group is half-open allowing a starting date right after completion of acute ECT treatment. Patients participate for 15 sessions, which are framed by 2 individual sessions before joining the group and one individual session at treatment end.
Study NCT04159285 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: Can include continuation ECT, psychopharmacological treatment, individual psychotherapy
Study NCT01743898 — intervention group
Intervention type: DRUG
Intervention: Rivaroxaban
Description: Patients will continue on their Rivaroxaban dose as previously prescribed by their individual physician. No dose adjustments will be made for the purpose of this study.
Study NCT01743898 — intervention group
Intervention type: OTHER
Intervention: no anticoagulation
Study NCT04309968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug: SYHA1801
Description: Drug: SYHA1801 administered orally
Study NCT00746850 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: early LC within 72 hours after the diagnosis with H (Harmonic)
Description: early laparoscopic cholecystectomy within 72 hours after the diagnosis of acute cholecystitis with H (Harmonic scalpel)
Study NCT00746850 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: early LC within 72 hours after the diagnosis with MD (Monopolar Diathermy)
Description: early laparoscopic cholecystectomy within 72 hours after the diagnosis of acute cholecystitis with MD (Monopolar Diathermy)
Study NCT02914743 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: This intervention will involve a discussion intended to explore subjects' motivations to pursue dental care and empower them to visit a dentist upon release from the hospital.
Study NCT02914743 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dental cleaning
Description: This procedure will involve the removal of plaque and supragingival and subgingival calculus from the surfaces of the teeth.
Study NCT05161962 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: One group received standard oral care.
Description: the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.
Study NCT05161962 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: One group received standard oral care.
Description: the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.
Study NCT05161962 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: It was applied to the other group by aspiration.
Description: the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.
Study NCT05161962 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: It was applied to the other group by aspiration.
Description: the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.
Study NCT00222846 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention control
Description: Participants attend 3 educational seminars, receive a lay diabetes journal, pedometer, and glucose monitoring supplies.
Study NCT00222846 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Behavioral intervention of diabetes self-management paired with PDA-based monitoring of dietary intake and physical activity. Participants also receive a pedometer and glucose self-monitoring supplies.
Study NCT02805166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEG-rhG-CSF
Study NCT05361252 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SVV-guided fluid management
Description: fluid will be guided by value of stroke volume variation
Study NCT00473772 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DEBlue stent vs. Cypher stent
Description: DES vs. DEB with BMS
Study NCT00473772 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DEBlue stent vs. Cypher stent
Description: DES vs. DEB with BMS
Study NCT01896713 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MS3TMRI
Description: Multispectral 3 Tesla MRI imaging with contrast followed by biopsy
Study NCT01937182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Citalopram
Description: Citalopram 10-40 mg per day administered orally
Study NCT01937182 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1/2-2 tablets per day with no intrinsic drug activity
Study NCT02119988 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TIPS
Description: TIPS will be performed with a standard technique. TIPS revision will be planned if any evidence of shunt dysfunction is observed.
Study NCT02119988 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TIPS
Description: TIPS will be performed with a standard technique. TIPS revision will be planned if any evidence of shunt dysfunction is observed.
Study NCT02119988 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Variceal Embolization
Description: Embolization of gastroesophageal collaterals will be conducted via the same jugular vein before TIPS implantation. The major procedures includ (a) angiography of gastroesophageal collaterals after successful intrahepatic puncture of a branch of the portal vein and (b) embolization of gastroesophageal collaterals with coils of varying diameters, which result in the gastroesophageal collaterals disappearing at postembolization angiography.
Study NCT04472039 — intervention group
Intervention type: DEVICE
Intervention: optical coherence tomography (OCT)
Description: OCT visualizes the retinal layers by backreflection of light
Study NCT01909024 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coil embolisation
Description: transjugular coil embolisation of pelvic veins
Study NCT01909024 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endovenous treatment of leg recurrent varicose veins
Description: endovenous treatment of leg recurrent varicose veins
Study NCT01909024 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: endovenous treatment of leg recurrent varicose veins
Description: endovenous treatment of leg recurrent varicose veins
Study NCT04304209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 130mg/m2, d1 q3w, in Capeox regimen (100mg/m2 when used cocurrently with radiotherapy), intravenous infusion
Study NCT04304209 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: 130mg/m2, d1 q3w, in Capeox regimen (100mg/m2 when used cocurrently with radiotherapy), intravenous infusion
Study NCT04304209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1000mg/m2, bid, qd1-14, q3w, in Capeox regimen, oral administration
Study NCT04304209 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: 1000mg/m2, bid, qd1-14, q3w, in Capeox regimen, oral administration
Study NCT04304209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200mg, d1 q3w, intravenous infusion
Study NCT04304209 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: neoadjuvant radiotherapy with 50Gy to GTV, 45Gy to CTV in 25 fractions.
Study NCT04304209 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiotherapy
Description: neoadjuvant radiotherapy with 50Gy to GTV, 45Gy to CTV in 25 fractions.
Study NCT04304209 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: total mesorectal excision
Description: total mesorectal excision after neoadjuvant treatment
Study NCT01190787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: velcade subcutaneous melphalan prednisone
Description: INDUCTION Velcade will be given as subcutaneous (SC) injection. Each cycle will be repeated every 28 days.~Melphalan will be given orally. Each cycle will be repeated every 28 days. Prednisone will be given orally.Each cycle will be repeated every 28 days. MAINTENANCE Velcade will be given a SC injection. Each cycle will be repeated every 28 days.
Study NCT01190787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: velcade cyclophosphamide prednisone
Description: INDUCTION Velcade will be given as subcutaneous (SC) injection. Each cycle will be repeated every 28 days.~Cyclophosphamide will be given orally. Each cycle will be repeated every 28 days.~Prednisone will be given orally.Each cycle will be repeated every 28 days. MAINTENANCE Velcade will be given a SC injection. Each cycle will be repeated every 28 days.
Study NCT01190787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: velcade prednisone
Description: INDUCTION Velcade will be given as subcutaneous (SC) injection. Each cycle will be repeated every 28 days.~Prednisone will be given orally.Each cycle will be repeated every 28 days. MAINTENANCE Velcade will be given a SC injection. Each cycle will be repeated every 28 days.
Study NCT03433729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient agenda form
Description: On arrival at the clinic patients are given an agenda form to prompt them to think about what issues they wished to discuss with their doctor. The form contains a prompt list of items they can tick, free space to write their own items, and a prompt to consider what is the most important issue for them and what they would like to happen before they leave their clinic appointment.
Study NCT00804037 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Injection Snoreplasty
Description: Injection of 0,5 ml of the sclerosing agent into the soft palate (3 points)
Study NCT04079673 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Patient controlled epidural analgesia
Description: Patient controlled epidural analgesia with marcaine 0.66mg/ml +fentanyl 1.75mcg/ml for postoperative pain control
Study NCT04079673 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Intravenous patient controlled analgesia
Description: Intravenous patient controlled analgesia with morphine 1mg/ml for postoperative pain control
Study NCT04459429 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Change of cannula size
Description: During nasal High Flow Therapy with fixed flow of 8 l/min, the cannula size will be changed from smaller-to-larger or larger-to-smaller
Study NCT02315443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nerinetide (NA-1)
Study NCT02315443 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04074876 — intervention group
Intervention type: DEVICE
Intervention: Pulmonary echography
Description: Pulmonary echography during preoperative evaluation for patients undergoing urgency orthopedic surgery for femur fracture.~Pulmonary ultrasound will evaluate the presence of one of four patterns defined by Lung Ultrasound Score in the 6 fields for each hemithorax of the patient (2 anterior, 2 lateral and 2 posterior). Each region is defined by axillary lines (anterior and posterior) and then is divided into 2 subregions (superior and inferior), thus defining the 6 fields. For a comprehensive exam, all intercostal spaces in the setting of each field will have to be examined by sliding the probe along them . A score will be used for each field that will have this definition:~* 0: normal pattern (A-lines)~* 1: multiple B lines (at least 3 for field), well defined.~* 2: B lines coalescent~* 3: consolidation of any dimension
Study NCT02702596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurement-Based Integrated Care
Description: Measurement-Based Integrated Care (MBIC) synthesizes the science of integrated health care and incorporates the strategies of measurement-based care. concept of MBIC for the treatment of depression includes: systematic assessment of symptoms, antidepressant treatment side effects and medication adherence and incorporation of a Depression Care Manager (DCM) to track patients and keep them engaged in care using behavioral interventions
Study NCT02702596 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Depression Education Fotonovela
Description: Depression education that uses a unique, culturally adapted depression fotonovela titled Secret Feelings developed by Cabassa, Molina and Baron (2012). The fotonovela is a popular comic-book style pamphlet that portrays a dramatic story using photographs and dialogue bubbles, which has become an effective tool for engaging Hispanic audiences and increasing knowledge about specific health issues
Study NCT02702596 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Education
Description: The the use of a pamphlet to educate people about depression.
Study NCT01401959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eribulin
Description: 1.4 mg/m\^2 IV Days 1 and 8, every 21 days for six cycles
Study NCT01401959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: 6 mg/kg IV Day 1 every 21 days
Study NCT00600054 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: nimotuzumab (anti EGFR humanized monoclonal antibody)
Description: 150 mg/m2 I.V. Induction phase: infusions once a week for 8 weeks. Consolidation phase: infusions once every 2 weeks for 10 weeks. Patients may then continue on the consolidation regimen of nimotuzumab, until disease progression or the occurrence of unacceptable toxicity.
Study NCT00879879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: losartan
Description: 50 mg losartan taken daily by mouth in capsule form for 1 year
Study NCT03239691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-709478 for oral use
Description: Hard gelatin capsules for oral administration formulated at strengths of 10 mg and 100 mg
Study NCT03239691 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo available as matching capsules for oral administration
Study NCT02514954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Biochaperone® Combo
Description: Subcutaneous injection of an individualized dose
Study NCT02514954 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Humalog® Mix25
Description: Subcutaneous injection of an individualized dose
Study NCT03445182 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local anaesthesia with conventional syringe
Description: Buccal infiltration in posterior maxillary region with traditional technique. A 27 gauge short needle is inserted in the mucobuccal fold above the tooth to be anesthetized.~Local anaesthetic infiltration speed 1ml/min. Drug: Local anaesthetic - Ubistesin - 4% Articaine with adrenaline 1: 200 000 1.7 mL
Study NCT03445182 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Local anaesthesia with conventional syringe + Dentalvibe
Description: Buccal infiltration in posterior maxillary region. The tip of the DentalVibe device is placed in the mucobuccal fold above the tooth to be anesthetized. The device is activated for 5 s. A 27 gauge short needle is inserted as close as possible to the inner side of the prong while the vibration is still on.~Local anaesthetic infiltration speed 1ml/min. After injection the needle is withdrawn and vibration continues for another 5 s.~Drug: Local anaesthetic - Ubistesin - 4% Articaine with adrenaline 1: 200 000 1.7 mL
Study NCT01346215 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: heparin sodium
Description: 5000 UI/mL